This company has been marked as potentially delisted and may not be actively trading. NASDAQ:PKBO Peak Bio (PKBO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Peak Bio Stock (NASDAQ:PKBO) 30 days 90 days 365 days Advanced Chart Get Peak Bio alerts:Sign Up Key Stats Today's Range$0.02▼$0.0250-Day Range$0.02▼$0.1152-Week Range$0.00▼$0.26Volume66,140 shsAverage Volume8,940 shsMarket Capitalization$520.31 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with inflammatory, cancer, and rare and specialty diseases. The company's lead product candidate is PHP-303, which is in phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate for solid tumors. The company was founded in 2020 and is based in Pleasanton, California. Read More Receive PKBO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Peak Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address PKBO Stock News HeadlinesAkari Therapeutics announce shareholder approval connected with Peak Bio mergerNovember 9, 2024 | markets.businessinsider.comAkari Therapeutics Plc: Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. MergerNovember 8, 2024 | finanznachrichten.deBanks aren’t ready for this altcoin—are you?In crypto, timing is everything. By the time the masses catch wind of this, the biggest gains could be ancient history. Are you ready to potentially change your financial future forever?July 2 at 2:00 AM | Crypto 101 Media (Ad)Peak Bio Inc (PKBO)October 19, 2024 | investing.comPeak Bio, Inc. (PKBO)September 28, 2024 | finance.yahoo.comAkari Therapeutics Plc: Rob Bazemore Appointed to the Board of Directors of Akari TherapeuticsSeptember 17, 2024 | finanznachrichten.deWhat Peak 65 Means for My Gen X ClientsAugust 29, 2024 | msn.comAKARI THER.ADR/2000 -,01 (CLA.MU)August 28, 2024 | uk.finance.yahoo.comSee More Headlines PKBO Stock Analysis - Frequently Asked Questions How were Peak Bio's earnings last quarter? Peak Bio, Inc. (NASDAQ:PKBO) issued its earnings results on Tuesday, November, 12th. The company reported $0.06 earnings per share (EPS) for the quarter. What other stocks do shareholders of Peak Bio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Peak Bio investors own include Check-Cap (CHEK), Pulmonx (LUNG), Minerva Neurosciences (NERV), Crescent Biopharma (CBIO), Adicet Bio (ACET), Absci (ABSI) and Aeglea BioTherapeutics (AGLE). Company Calendar Last Earnings11/12/2024Today7/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:PKBO CIK1834645 Webpeak-bio.com Phone650-549-9103FaxN/AEmployees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.83 million Net MarginsN/A Pretax Margin-4,433.33% Return on EquityN/A Return on Assets-179.31% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.06 Sales & Book Value Annual Sales$370 thousand Price / Sales1.41 Cash FlowN/A Price / Cash FlowN/A Book Value($0.90) per share Price / Book-0.03Miscellaneous Outstanding Shares23,125,000Free Float18,523,000Market Cap$520.31 thousand OptionableNot Optionable Beta1.75 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:PKBO) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Peak Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Peak Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.